Short answer · Medically reviewed summary · Last updated: 2026-04-07
Familial Mediterranean Fever (FMF) is an autoinflammatory disorder historically known as periodic disease or benign paroxysmal peritonitis. While older literature may use various terms, Familial Mediterranean Fever is the standard clinical name used in modern medical practice and international classification systems. Why does Familial Mediterranean Fever have multiple names? The naming of Familial Mediterranean Fever has evolved significantly since it was first described in the mid-20th century.
Familial Mediterranean Fever (FMF) is an autoinflammatory disorder historically known as periodic disease or benign paroxysmal peritonitis. While older literature may use various terms, Familial Mediterranean Fever is the standard clinical name used in modern medical practice and international classification systems.
The naming of Familial Mediterranean Fever has evolved significantly since it was first described in the mid-20th century. Historically, physicians observed recurring episodes of fever and inflammation but did not yet understand the underlying genetic cause, leading to descriptive names based on clinical presentation. As medical science progressed and the MEFV gene was identified in 1997, the medical community moved toward the more precise term Familial Mediterranean Fever to reflect both the hereditary nature and the common geographic ancestry of affected populations.
In older medical charts or research papers, you may encounter several synonyms. Recognizing these terms is helpful when reviewing historical family medical records or older clinical studies. Common alternative names include:
To ensure consistency in global healthcare, Familial Mediterranean Fever is categorized under specific codes in major medical databases. Using these codes can be essential for insurance claims and clinical documentation. Official classifications include:
Today, Familial Mediterranean Fever is the universally accepted terminology preferred by rheumatologists, geneticists, and researchers. Using this specific name ensures that your healthcare providers are accessing the most current clinical guidelines for treatment, such as the use of colchicine to prevent systemic amyloidosis. Within the DiseaseMaps.org community, where 264 individuals share their experiences, using the standard term Familial Mediterranean Fever helps connect patients with relevant clinical trials, support groups, and the latest research updates.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.